Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Market Cap	551.01B +9.6%
Revenue (ttm)	335.80B +13.6%
Net Income	34.54B +16.8%
EPS	148.61 +14.9%
Shares Out	225.96M
PE Ratio	16.41
Forward PE	16.53
Dividend	46.00 (1.89%)
Ex-Dividend Date	Mar 30, 2026

Volume	404,100
Average Volume	665,540
Open	2,450.00
Previous Close	2,436.50
Day's Range	2,429.50 - 2,458.50
52-Week Range	1,964.50 - 2,703.00
Beta	-0.47
RSI	50.36
Earnings Date	May 12, 2026

About Rohto Pharmaceutical

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatologi...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1899
• Employees: 9,144
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4527

Financial Performance

In fiscal year 2025, Rohto Pharmaceutical's revenue was 308.63 billion, an increase of 13.95% compared to the previous year's 270.84 billion. Earnings were 31.01 billion, an increase of 0.23%.